List of Tables
Table 1 Market, By Type, 2017-2024 (USD Million)
Table 2 Standalone Cancer Patient Registry Software: Market, By Region, 2017-2024 (USD Million)
Table 3 North America: Standalone Cancer Patient Registry Software: Market, By Country, 2017-2024 (USD Million)
Table 4 Europe: Standalone Cancer Patient Registry Software: Market, By Country, 2017-2024 (USD Million)
Table 5 Integrated Cancer Patient Registry Software: Market, By Region, 2017-2024 (USD Million)
Table 6 North America: Integrated Cancer Patient Registry Software: Market, By Country, 2017-2024 (USD Million)
Table 7 Europe: Integrated Cancer Patient Registry Software: Market, By Country, 2017-2024 (USD Million)
Table 8 Market, By Deployment Model, 2017-2024 (USD Million)
Table 9 Market for On-Premise Models, By Region, 2017-2024 (USD Million)
Table 10 North America: Market for On-Premise Models, By Country, 2017-2024 (USD Million)
Table 11 Europe: Market for On-Premise Models, By Country/Region, 2017-2024 (USD Million)
Table 12 Market for Cloud-Based Models, By Region, 2017-2024 (USD Million)
Table 13 North America: Market for Cloud-Based Models, By Country, 2017-2024 (USD Million)
Table 14 Europe: Market for Cloud-Based Models, By Country/ Region, 2017-2024 (USD Million)
Table 15 Market, By Database Type, 2017-2024 (USD Million)
Table 16 Market for Commercial Databases, By Region, 2017-2024 (USD Million)
Table 17 North America: Market for Commercial Databases, By Country, 2017-2024 (USD Million)
Table 18 Europe: Market for Commercial Databases, By Country, 2017-2024 (USD Million)
Table 19 Market for Public Databases, By Region, 2017-2024 (USD Million)
Table 20 North America: Market for Public Databases, By Country, 2019-2024 (USD Million)
Table 21 Europe: Market for Public Databases, By Country, 2019-2024 (USD Million)
Table 22 Market, By Functionality, 2017-2024 (USD Million)
Table 23 Market for Cancer Reporting to Meet State and Federal Regulations, By Region, 2017-2024 (USD Million)
Table 24 North America: Market for Cancer Reporting to Meet State and Federal Regulations, By Country, 2017-2024 (USD Million)
Table 25 Europe: Market for Cancer Reporting to Meet State and Federal Regulations, By Country, 2017-2024 (USD Million)
Table 26 Market for Patient Care Management, By Region, 2017-2024 (USD Million)
Table 27 North America: Market for Patient Care Management, By Country, 2017-2024 (USD Million)
Table 28 Europe: Market for Patient Care Management, By Country, 2017-2024 (USD Thousand)
Table 29 Market for Medical Research & Clinical Studies, By Region, 2017-2024 (USD Million)
Table 30 North America: Market for Medical Research & Clinical Studies, By Country, 2017-2024 (USD Million)
Table 31 Europe: Market for Medical Research & Clinical Studies, By Country, 2017-2024 (USD Million)
Table 32 Market for Product Outcome Evaluation, By Region, 2017-2024 (USD Million)
Table 33 North America: Market for Product Outcome Evaluation, By Country, 2017-2024 (USD Million)
Table 34 Europe: Market for Product Outcome Evaluation, By Country, 2017-2024 (USD Million)
Table 35 Market, By End User, 2017-2024 (USD Million)
Table 36 Market for Government Organizations & Third-Party Administrators, By Region, 2017-2024 (USD Million)
Table 37 North America: Market for Government Organizations & Third-Party Administrators, By Country, 2017-2024 (USD Million)
Table 38 Europe: Market for Government Organizations & Third-Party Administrators, By Country, 2017-2024 (USD Million)
Table 39 Market for Hospitals & Medical Practices, By Region, 2017-2024 (USD Million)
Table 40 North America: Market for Hospitals & Medical Practices, By Country, 2017-2024 (USD Million)
Table 41 Europe: Market for Hospitals & Medical Practices, By Country, 2017-2024 (USD Million)
Table 42 Market for Private Payers, By Region, 2017-2024 (USD Million)
Table 43 North America: Market for Private Payers, By Country, 2017-2024 (USD Million)
Table 44 Europe: Market for Private Payers, By Country, 2017-2024 (USD Thousand)
Table 45 Cancer Registry Software Market for Pharmaceutical, Biotechnology, and Medical Device Companies, By Region, 2017-2024 (USD Million)
Table 46 North America: Cancer Registry Software Market for Pharmaceutical, Biotechnology, and Medical Device Companies, By Country, 2017-2024 (USD Million)
Table 47 Europe: Cancer Registry Software Market for Pharmaceutical, Biotechnology, and Medical Device Companies, By Country, 2017-2024 (USD Million)
Table 48 Cancer Registry Software Market for Research Centers, By Region, 2017-2024 (USD Million)
Table 49 North America: Cancer Registry Software Market for Research Centers, By Country, 2017-2024 (USD Million)
Table 50 Europe: Cancer Registry Software Market for Research Centers, By Country, 2017-2024 (USD Million)
Table 51 Cancer Registry Software Market, By Region, 2017-2024 (USD Million)
Table 52 North America: Cancer Registry Software Market, By Country, 2017-2024 (USD Million)
Table 53 North America: Cancer Registry Software Market, By Type, 2017-2024 (USD Million)
Table 54 North America: Cancer Registry Software Market, By Deployment Model, 2017-2024 (USD Million)
Table 55 North America: Cancer Registry Software Market, By Database Type, 2017-2024 (USD Million)
Table 56 North America: Cancer Registry Software Market, By Functionality, 2017-2024 (USD Million)
Table 57 North America: Cancer Registry Software Market, By End User, 2017-2024 (USD Million)
Table 58 US: Cancer Registry Software Market, By Type, 2017-2024 (USD Million)
Table 59 US: Cancer Registry Software Market, By Deployment Model, 2017-2024 (USD Million)
Table 60 US: Cancer Registry Software Market, By Database Type, 2017-2024 (USD Million)
Table 61 US: Cancer Registry Software Market, By Functionality, 2017-2024 (USD Million)
Table 62 US: Cancer Registry Software Market, By End User, 2017-2024 (USD Million)
Table 63 Canada: Cancer Registry Software Market, By Type, 2017-2024 (USD Million)
Table 64 Canada: Cancer Registry Software Market, By Deployment Model, 2017-2024 (USD Million)
Table 65 Canada: Cancer Registry Software Market, By Database Type, 2017-2024 (USD Million)
Table 66 Canada: Cancer Registry Software Market, By Functionality, 2017-2024 (USD Million)
Table 67 Canada: Cancer Registry Software Market, By End User, 2017-2024 (USD Million)
Table 68 Europe: Cancer Registry Software Market, By Country, 2017-2024 (USD Million)
Table 69 Europe: Cancer Registry Software Market, By Type, 2017-2024 (USD Million)
Table 70 Europe: Cancer Registry Software Market, By Deployment Model, 2017-2024 (USD Million)
Table 71 Europe: Cancer Registry Software Market, By Database Type, 2017-2024 (USD Million)
Table 72 Europe: Cancer Registry Software Market, By Functionality, 2017-2024 (USD Million)
Table 73 Europe: Cancer Registry Software Market, By End User, 2017-2024 (USD Million)
Table 74 UK: Cancer Registry Software Market, By Type, 2017-2024 (USD Million)
Table 75 UK: Cancer Registry Software Market, By Deployment Model, 2017-2024 (USD Million)
Table 76 UK: Cancer Registry Software Market, By Database Type, 2017-2024 (USD Million)
Table 77 UK: Cancer Registry Software Market, By Functionality, 2017-2024 (USD Million)
Table 78 UK: Cancer Registry Software Market, By End User, 2017-2024 (USD Million)
Table 79 Germany: Patient Registry Software Market, By Type, 2017-2024 (USD Million)
Table 80 Germany: Patient Registry Software Market, By Deployment Model, 2017-2024 (USD Million)
Table 81 Germany: Cancer Registry Software Market, By Database Type, 2017-2024 (USD Million)
Table 82 Germany: Cancer Registry Software Market, By Functionality, 2017-2024 (USD Million)
Table 83 Germany: Cancer Registry Software Market, By End User, 2017-2024 (USD Million)
Table 84 France: Cancer Registry Software Market, By Type, 2017-2024 (USD Million)
Table 85 France: Cancer Registry Software Market, By Deployment Model, 2017-2024 (USD Million)
Table 86 France: Cancer Registry Software Market, By Database Type, 2017-2024 (USD Million)
Table 87 France: Cancer Registry Software Market, By Functionality, 2017-2024 (USD Million)
Table 88 France: Cancer Registry Software Market, By End User, 2017-2024 (USD Million)
Table 89 RoE: Market, By Type, 2017-2024 (USD Million)
Table 90 RoE: Market, By Deployment Model, 2017-2024 (USD Million)
Table 91 RoE: Market, By Database Type, 2017-2024 (USD Million)
Table 92 RoE: Market, By Functionality, 2017-2024 (USD Million)
Table 93 RoE: Market, By End User, 2017-2024 (USD Million)
Table 94 Product Enhancements, 2016-2018
Table 95 Acquisitions, 2016-2018
Table 96 Collaborations, 2016-2018
List of Figures
Figure 1 Cancer Patient Registry Software: Market Segmentation
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Cancer Patient Registry Software: Market, By Type, 2019 vs 2024 (USD Million)
Figure 8 Cancer Patient Registry Software: Market, By Deployment Model, 2019 vs 2024 (USD Million)
Figure 9 Cancer Patient Registry Software: Market, By Database Type, 2019 vs 2024 (USD Million)
Figure 10 Cancer Patient Registry Software: Market, By Functionality, 2019 vs 2024 (USD Million)
Figure 11 Research Centers Segment is Expected to Witness the Highest CAGR During the Forecast Period
Figure 12 Rising Pressure to Improve the Quality of Care and Reduce Healthcare Costs to Drive Market Growth
Figure 13 Integrated Software Segment to Grow at the Fastest Rate During the Forecast Period
Figure 14 On-Premise Models to Hold the Largest Share of the Market in 2019
Figure 15 Commercial Database Segment to Dominate the Market in 2019
Figure 16 Cancer Reporting to Meet State & Federal Regulations Segment to Dominate the Market in 2019
Figure 17 Hospitals and Medical Practices Segment to Dominate the Market in 2019
Figure 18 Cancer Patient Registry Software: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Integrated Software Segment is Expected to Register High Growth During the Forecast Period
Figure 20 Cloud-Based Models Segment is Expected to Witness the Higher CAGR During the Forecast Period
Figure 21 Commercial Databases Segment to Dominate the Cancer Patient Registry Software: Market During the Forecast Period
Figure 22 Medical Research & Clinical Studies Segment is Expected to Witness the Highest Growth Rate During the Forecast Period
Figure 23 Research Centers - the Fastest-Growing End-User Segment in the Cancer Patient Registry Software: Market
Figure 24 North America: Cancer Patient Registry Software: Market Snapshot
Figure 25 Europe: Cancer Patient Registry Software: Market Snapshot
Figure 26 Key Developments in the Cancer Patient Registry Software: Market From 2016 to November 2018
Figure 27 Cancer Patient Registry Software: Market Player Ranking, 2018
Figure 28 Elekta AB (PUB): Company Snapshot
Figure 29 Mckesson Corporation: Company Snapshot